LSTA1-GBM-2A: study protocol for an exploratory phase 2a randomised controlled trial evaluating tumour-homing peptide certepetide with temozolomide in glioblastoma multiforme
LSTA1-GBM-2A: study protocol for an exploratory phase 2a randomised controlled trial evaluating tumour-homing peptide certepetide with temozolomide in glioblastoma multiforme
Hiie Soeorg, Kristen Buck, Tambet Teesalu, Katrin Kaarna et al.
Journal
BMJ Open
Topics
Glioma Diagnosis and Treatment
article
LSTA1-GBM-2A: study protocol for an exploratory phase 2a randomised controlled trial evaluating tumour-homing peptide certepetide with temozolomide in glioblastoma multiforme
Hiie Soeorg, Kristen Buck, Tambet Teesalu, Katrin Kaarna, William K. Sietsema, Kersti Oselin, Kadri Toome, Jana Lass, Lenne‐Triin Körgvee, Johannes Pärtel Truusalu
article en
Abstract
No abstract available for this paper.
Publication Tag
BMJ OpenVol. 15(11)
Institutions
University of California, Santa Barbara (US), Tartu University Hospital (EE), North Estonia Medical Centre (EE), Reproductive Medicine Associates of New Jersey (US), University College London (GB), University of Tartu (EE)